StockData

Intercure Ltd. (INCR) stock

INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 3/30
$3.63−0.16 (-4.22%)

Close on Nov 16, 2026Market cap $198.49MP/E –Yield –

Intercure total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Intercure's total debt was 195.30M ILS at Dec 31, 2025. For fiscal 2025 it was 195.30M ILS, down 12.7% from the year before. The highest annual figure on record is 226.62M ILS in fiscal 2022.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025195.30M ILS-12.7%
FY2024Dec 31, 2024223.65M ILS+1.4%
FY2023Dec 31, 2023220.66M ILS-2.6%
FY2022Dec 31, 2022226.62M ILS+174.9%
FY2021Dec 31, 202182.44M ILS+10965.2%
FY2020Dec 31, 2020745.00K ILS–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025195.30M ILS+136.9%
Q4 FY2024Dec 31, 2024223.65M ILS+29920.3%
Q4 FY2023Dec 31, 2023220.66M ILS–
Q4 FY2022Dec 31, 2022226.62M ILS–
Q4 FY2021Dec 31, 202182.44M ILS–
Q4 FY2020Dec 31, 2020745.00K ILS–

More Intercure figures

See a number that looks wrong?